Loading...

XXII 22ND CENTURY GROUP INC Investments/Divestments 8-K Filing

22ND

XX

22ND CENTURY GROUP INC

(XXII)

2024 8-K

Show Summary

Show Summary

Reverse Stock Split

Debt-Equity Swaps

Earnings Releases

Rights Offerings

Settlement Agreement

Earnings Release

Nasdaq Compliance

Conversion Price Reset

New Licensing Agreement

Stock Delisting Notice

Stockholder Meeting

Securities Agreement

Securities Offering

Capital Structure Change

Nasdaq Compliance

Nasdaq Compliance

Securities Offering

Payment Agreement

Capital Raise Details

Conference Announcement

Earnings Release

Appointment of New Executiv...

Compliance with Nasdaq List...

Departure of Directors

Earnings Release

Agreement Modification and ...

Settlement Agreement with O...

Resignation of Directors

Securities Purchase Agreement

Debt Conversion and Securit...

Reverse Stock Split

Earnings Release

Amendment to Articles of In...

Compensation Reduction

Termination of Employment A...

Special Meeting of Stockhol...

Sale of GVB hemp/cannabis b...

Termination of Officer

Warrant Inducement Offering

Equity Purchase Agreement

Licensing Agreement

Earnings Release

Securities Purchase Agreement

Agreement and Modification

Retention Agreements

Earnings Release

Management Changes, Asset Sale

Securities Purchase Agreement

Earnings Release

Departure of Officer

Investment Agreement

Sales Agreement

Earnings Release

Securities Purchase Agreement

Acquisition of RX Pharmatec...

External Links:

GVB Biopharma made a payment of $1.5 million to reduce the company's outstanding debt with JGB Partners, LP.

AI Assistant

22ND CENTURY GROUP INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.